Intervention Review

Rofecoxib for rheumatoid arthritis

  1. Sarah E Garner1,*,
  2. Dogan Fidan2,
  3. Ruth R Frankish1,
  4. Maria Judd3,
  5. Tanveer Towheed4,
  6. Peter Tugwell5,
  7. George A Wells6

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 24 JAN 2005

Assessed as up-to-date: 16 NOV 2004

DOI: 10.1002/14651858.CD003685.pub2

How to Cite

Garner SE, Fidan D, Frankish RR, Judd M, Towheed T, Tugwell P, Wells GA. Rofecoxib for rheumatoid arthritis. Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD003685. DOI: 10.1002/14651858.CD003685.pub2.

Author Information

  1. 1

    National Institute for Clinical Excellence, Appraisals Team, London, UK

  2. 2

    Aventis Pharma Ltd., Health Economics Unit, London, UK

  3. 3

    Canadian Health Services Research Foundation/Fondation canadienne de la recherche sur les services de santé, Research Use/Agente principale de programme, Utilisation de la Recherche, Ottawa, Ontario, Canada

  4. 4

    Queen's University, Department of Medicine and of Community Health and Epidemiology, Kingston, Ontario, Canada

  5. 5

    Ottawa Hospital, Centre for Global Health, Institute of Population Health, Department of Medicine, Ottawa, Ontario, Canada

  6. 6

    University of Ottawa Heart Institute, Cardiovascular Research Reference Centre, Ottawa, Ontario, Canada

*Sarah E Garner, Appraisals Team, National Institute for Clinical Excellence, MidCity Place, 71 High Holborn, London, WC1V 6NA, UK.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 24 JAN 2005


Cited in:


This article has been cited by:

  1. 1
    Mareike K. Thompson, John S. Axford, Nidhi Sofat, Rheumatoid arthritis in 2011: An editorial, Best Practice & Research Clinical Rheumatology, 2011, 25, 4, 435


  2. 2
    Peter Tugwell, Lara Maxwell, Vivian Welch, Elizabeth Kristjansson, Mark Petticrew, George Wells, Rachelle Buchbinder, Maria E. Suarez-Almazor, Marie-Andrée Nowlan, Erin Ueffing, Maryam Khan, Bev Shea, Setorme Tsikata, Is health equity considered in systematic reviews of the cochrane musculoskeletal group?, Arthritis Care & Research, 2008, 59, 11
  3. 3
    Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: An American College of Rheumatology white paper, Arthritis Care & Research, 2008, 59, 8
  4. 4
    Kaleb Michaud, Frederick Wolfe, Comorbidities in rheumatoid arthritis, Best Practice & Research Clinical Rheumatology, 2007, 21, 5, 885


  5. 5
    John H. Noble, Meta-analysis: Methods, strengths, weaknesses, and political uses, Journal of Laboratory and Clinical Medicine, 2006, 147, 1, 7